Acutus medical reports second quarter 2023 financial results

Carlsbad, calif., aug. 07, 2023 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2023.
AFIB Ratings Summary
AFIB Quant Ranking